Your browser doesn't support javascript.
loading
Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease.
AlQahtani, Manaf; Kumar, Nitya; Aljawder, Dhuha; Abdulrahman, Abdulkarim; Mohamed, Mohammed Wael; Alnashaba, Fatema; Fayyad, Mohammed Abu; Alshaikh, Faisal; Alsahaf, Fatima; Saeed, Sawsan; Almahroos, Amal; Abdulrahim, Zainab; Otoom, Sameer; Atkin, Stephen L.
  • AlQahtani M; National Task Force for Combating the Corona Virus (COVID-19), Riffa, Bahrain. mqahtani@rcsi-mub.com.
  • Kumar N; Bahrain Defence Force Hospital, Riffa, Bahrain. mqahtani@rcsi-mub.com.
  • Aljawder D; Royal College of Surgeons in Ireland, Riffa, Bahrain. mqahtani@rcsi-mub.com.
  • Abdulrahman A; Royal College of Surgeons in Ireland, Riffa, Bahrain.
  • Mohamed MW; Salmaniya Medical Complex, Manama, Bahrain.
  • Alnashaba F; National Task Force for Combating the Corona Virus (COVID-19), Riffa, Bahrain.
  • Fayyad MA; Sheikh Mohammed Bin Khalifa Cardiac Centre, Riffa, Bahrain.
  • Alshaikh F; King Hamad University Hospital, Muharraq, Kingdom of Bahrain.
  • Alsahaf F; Salmaniya Medical Complex, Manama, Bahrain.
  • Saeed S; Royal College of Surgeons in Ireland, Riffa, Bahrain.
  • Almahroos A; Bahrain Defence Force Hospital, Riffa, Bahrain.
  • Abdulrahim Z; Salmaniya Medical Complex, Manama, Bahrain.
  • Otoom S; Royal College of Surgeons in Ireland, Riffa, Bahrain.
  • Atkin SL; Salmaniya Medical Complex, Manama, Bahrain.
Sci Rep ; 12(1): 4925, 2022 03 23.
Article en En | MEDLINE | ID: mdl-35322077

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 / Hidroxicloroquina Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 / Hidroxicloroquina Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article